The most frequent genetic alteration in GBMs is an amplification of the Epidermal Growth Factor Receptor (EGFR) gene and/or its overexpression at the protein level, which is present in 40–60% of all GBM cases [36, 37]. This evidence concerns the gene EGFR and glioblastoma.